CAS RN: 1852-17-1
Tetrahydro-2-pyrimidinone
Product Availability
Choose a grade to view its available package options.
6 package records 6 with current stock 2 grade groups
Grade
97% (5)
98% (1)
In stock only
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20260518
100g
In stock
Shanghai Inquiry
Batchno.20251101
10g
In stock
Shanghai Inquiry
Batchno.20250811
25g
In stock
Shanghai Inquiry
Batchno.20260107
500g
In stock
Shanghai Inquiry
Batchno.20251210
5g
In stock
Shanghai Inquiry
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20250810
25g / 100g / 500g
Confirm by inquiry
Shanghai, Shandong, Guangdong 8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 100g
Available purity: ≥97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1852-17-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
100g
≥97%
0
Out of Stock
Shanghai
Inquiry
1852-17-1 / 1,3-diazinan-2-one
Standard CAS: 1852-17-1
Multi CAS: No
Basic Information
copy
CAS
1852-17-1 copy
Multi CAS
No copy
Molecular Formula
C4H8N2O copy
Molecular Weight
100.120000 copy
Exact Mass
100.063663 copy
SMILES
C1CNC(=O)NC1 copy
InChI
InChI=1S/C4H8N2O/c7-4-5-2-1-3-6-4/h1-3H2,(H2,5,6,7) copy
InChIKey
NQPJDJVGBDHCAD-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
7 copy
Fraction Csp3
0.75 copy
H-bond acceptors
1 copy
H-bond donors
2 copy
Molar refractivity
26.02 copy
TPSA
41.13 copy
LogP / Solubility
WLOGP
-0.31 copy
MLOGP
-0.29 copy
XLogP3
-1.3 copy
Consensus LogP
-0.63 copy
Log S (ESOL)
-0.27 copy
Class (ESOL)
Very soluble copy
Log S (Ali)
-0.16 copy
Class (Ali)
Very soluble copy
Log S (SILICOS-IT)
-0.05 copy
Class (SILICOS-IT)
Very soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.55 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy
Safety & Transport
copy
GHS Hazard Statements
Not Classified
Reported as not meeting GHS hazard criteria by 105 of 106 companies (only 0.9% companies provided GHS information). For more detailed information, please visit ECHA C&L website. copy